Regenxbio, Inc. (RGNX) CEO Kenneth Mills on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/08/19
Are Options Traders Betting on a Big Move in REGENXBIO (RGNX) Stock?Zacks Investment Research • 07/02/19
Approval of a Game-Changing Gene Therapy for SMA Delivers a Win for Novartis and RegenxbioThe Motley Fool • 05/24/19
Regenxbio, Inc. (RGNX) CEO Kenneth Mills on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/08/19
A Second Baby Died In A Gene Therapy Study — Slugging This Biotech StockInvestors Business Daily • 04/22/19